The Icahn School of Medicine at Mount Sinai will award its 2025 Yergin-New International Prize for Biomedical Research to Michael J. Welsh, MD, of the University of Iowa for his pioneering work in cystic fibrosis (CF), which has significantly advanced understanding and treatment of this chronic, inherited lung disease with an onset in children. This prize, formerly known as the Maria I. New International Prize for Biomedical Research, honors medical innovators who exemplify the values and dedication of the late Maria I. New, MD, a world-renowned researcher in pediatric genetic disorders who maintained special focus on endocrinology throughout her six-decade career. Dr. Welsh will receive a $50,000 award and will deliver the Maria I. New Distinguished Lecture during a ceremony to be held at Mount Sinai in New York City.

A landmark study in China covering 42,703 families affected by rare diseases across 32 provincial regions of China has established a new diagnosis framework for rare diseases. It offers new hope to millions of patients struggling with delayed or incorrect diagnoses.